Tag: Kidney Problems: Misc.
Symptom Burden Increases in Year Before Dialysis Initiation
Among older adults, symptom number and burden stabilized and decreased in the year after dialysis
Personalized Screening for Kidney Disease Evaluated in T1DM
Compared with annual screening for urinary albumin, personalized screening can reduce time spent with undetected albuminuria, testing frequency
ASN: Empagliflozin Cuts Risk for Progression in CKD
Risk for progression of kidney disease or death from cardiovascular causes reduced with empagliflozin versus placebo
ASN: Discontinuation of RAS Inhibitors Does Not Increase eGFR in CKD
No difference seen with discontinuation, continuation of RAS inhibitors among patients with advanced, progressive chronic kidney disease
CKD Incidence Differs by Race in People With Diabetes
Incidence lower in White patients versus Black, Hispanic, and indigenous populations
Second, Third COVID-19 Vaccine May Up Relapse in Glomerular Disease
Absolute increase in 30-day relapse risk associated with the second or third vaccine dose is small
Dapagliflozin May Be Cost-Effective for Treating CKD
Dapagliflozin for the treatment of chronic kidney disease cost-effective at willingness-to-pay thresholds of $27,510 and $35,503 per QALY in U.K. and Germany, Spain
Benefit of Ticagrelor-Aspirin in Stroke Patients Tied to Renal Function
Stroke patients with normal, but not those with impaired, renal function have greater benefit with ticagrelor-aspirin than clopidogrel-aspirin
Psoriasis Not Tied to Myocardial Infarction in Patients With ESRD
Confounding variables, particularly comorbidities, impact association
